The European AI in antibody discovery market is witnessing a considerable surge, driven primarily by growing investments in biotechnology and a heightened focus on personalized medicine. Researchers anticipate remarkable advancements in therapeutic antibody development utilizing artificial intelligence, particularly within areas like oncology and i